ETF1 antibody: RN111PW


Antibody Info
Product_IDRN111PW
Lot_ID1
Host_organismrabbit
SourceMBLI
Antibody_DCC_IDENCAB767NXE
Target Info
GeneNameETF1
Phosphate
Target_nameETF1-human

Validation Images
Cell linePrimary validationSecondary validation
HepG2 HepG2_MBLI_RN111PW_001_ETF1.png<br>Caption: IP-Western Blot analysis of HepG2 whole cell lysate using ETF1 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-ETF1 antibody (lanes under 'ETF1').

Caption: IP-Western Blot analysis of HepG2 whole cell lysate using ETF1 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-ETF1 antibody (lanes under 'ETF1').

Method: immunoprecipitation

Status: Released

Lab: Yeo Lab

ETF1-HEPG2.png<br>Caption: Western blot following shRNA against ETF1 in HepG2 whole cell lysate using ETF1 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against ETF1.ETF1 protein appears as the green band, GAPDH serves as a control and appears in red.

Caption: Western blot following shRNA against ETF1 in HepG2 whole cell lysate using ETF1 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against ETF1.ETF1 protein appears as the green band, GAPDH serves as a control and appears in red.

Releated Sample: BGHLV37-19

Status: Released

Lab: Graveley Lab

K562 K562_MBLI_RN111PW_001_ETF1.png<br>Caption: IP-Western Blot analysis of K562 whole cell lysate using ETF1 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-ETF1 antibody (lanes under 'ETF1').

Caption: IP-Western Blot analysis of K562 whole cell lysate using ETF1 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-ETF1 antibody (lanes under 'ETF1').

Method: immunoprecipitation

Status: Released

Lab: Yeo Lab

ETF1-K562-CRISPR.png<br>Caption: Western blot following CRISPR against ETF1 in K562 whole cell lysate using ETF1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against ETF1.ETF1 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Caption: Western blot following CRISPR against ETF1 in K562 whole cell lysate using ETF1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against ETF1.ETF1 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Releated Sample: BGKcLV08-33

Status: Released

Lab: Graveley Lab